Strategic Partnerships Coreline Soft is actively expanding in Europe and has formalized partnerships with INFINITT North America and Bayer, plus ongoing work with Charité in Germany. This indicates strong potential to cross-sell AI-driven thoracic imaging solutions to large healthcare networks, university hospitals, and pharma-affiliated research centers.

Enterprise Deployment The AVIEW platform is positioned for multi-center, population-based screening programs and routine clinical workflows, complemented by AVIEW HUB for centralized operations. This suggests opportunities to sell scalable platform deployments, integration services, and governance features to large health systems and national screening programs.

Regulatory and Reimbursement Recent launches such as the INFINITT Integration Suite and CPT-based reimbursement support indicate a focus on reducing implementation friction and connecting AI tools to billing workflows, a compelling angle for financial officers seeking ROI through reimbursement-ready solutions.

Global Validation Official AI provider for Korea’s K-LUCAS and active deployments across European screening initiatives position Coreline Soft as a trusted, validated vendor. This can be leveraged to approach regional health ministries, public health agencies, and hospital networks prioritizing validated AI in thoracic imaging.

High-Impact Use Cases Focus areas include early lung cancer detection, COPD and CAC analysis, and population-based screening. These high-value outcomes align with payer and hospital quality programs, offering opportunities to upsell expanded modules, workflow optimization, and data-driven population health initiatives.